CD274 and neoplasm: This result introduced PD-L1 as a ‘molecular shield’ that can protect tumor cells from T cell cytotoxicity caused by various treatments (Azuma et al, 2008), including IFNs (Gato-Canas et al, 2017; Gupta et al, 2016).